---
layout: post
title: "Targeting lipid droplets in FUS-linked amyotrophic lateral sclerosis mitigates neuronal and astrocytic lipotoxicity."
author: "Habakuk Hain"
categories: transmission
tags: ["FUS-ALS", "lipid droplets", "mitochondrial beta-oxidation"]
image:
rating: 8
paper_title: "Targeting lipid droplets in FUS-linked amyotrophic lateral sclerosis mitigates neuronal and astrocytic lipotoxicity."
paper_author: "Marcadet"
paper_journal: "Brain"
paper_year: "2026"
paper_doi: "https://doi.org/10.1093/brain/awaf328"
paper_et_al: true
summary: "This study reveals that FUS-linked ALS involves pathological accumulation of lipid droplets and disrupted fatty acid metabolism in neurons and astrocytes, leading to lipotoxicity. The authors demonstrate that arimoclomol, a drug previously tested in ALS trials, works by enhancing mitochondrial lipid metabolism and reducing this lipotoxicity through CPT1-dependent mechanisms."
author_context: "Research team from CERVO Brain Research Centre at Laval University with metabolomics expertise, combining preclinical models with human post-mortem tissue validation"
---

**Problem**: The downstream consequences of metabolic reprogramming toward fatty acid utilization in ALS pathogenesis were poorly understood.

**Result**: FUS-ALS involves pathological lipid droplet accumulation and lipotoxicity in neurons and astrocytes, which can be mitigated by enhancing CPT1-dependent mitochondrial Î²-oxidation.

**Open Questions**: Whether this lipid metabolic dysfunction occurs across other ALS subtypes and whether CPT1-targeting therapies could be developed for clinical translation.
